Skip to main content

Cepheid, Bruker, and Qiagen Shares All Rise in Double Digits

The stocks of Cepheid, Bruker BioSciences, and Qiagen all gained more than 10 percent for the five-day trading period ended Tuesday.
 
Cepheid led all gainers in the BCW Index for the week with a 12.6 percent rise in its shares. The firm is due to report its third-quarter results on Nov. 1.
 
Bruker BioSciences shares bumped up 11.6 percent after the firm posted strong revenue and profit gains earlier this week. Shares of Qiagen hit a new 52-week high of $23.65 on Tuesday before closing at $23.55, up 11.1 percent for the tracking period.
 
Illumina led all declining shares in the Index with a drop of 10.3 percent for the week. Shares of Affymetrix, which filed additional patent infringement suits against Illumina last week (see Briefs), fell 9.2 percent.
 
Overall, the Index declined .8 percent. The Dow Jones Industrial Average gained .8 percent for the tracking period, while the Nasdaq rose .6 percent, and the Nasdaq Biotech Index dropped .3 percent.
 
 


BioCommerce Week Index of Diversified
Molecular Biology Tool Companies
Company
Ticker
Current Price
(October 30, 2007)
Last
Price
(October 23, 2007)
% change
Affymetrix
AFFX
24.80 27.31 -9.19
Agilent
A
35.86 37.33 -3.94
Applied Biosystems
ABI
36.01 35.22 2.24
Beckman
BEC
70.14 73.86 -5.04
Becton Dickinson
BDX
83.44 81.77 2.04
Bio-Rad
BIO
95.36 95.07 0.31
Bruker
BRKR
10.17 9.11 11.64
Caliper
CALP
5.85 5.85 0.00
Cepheid
CPHD
26.07 23.15 12.61
Illumina
ILMN
55.93 62.38 -10.34
Invitrogen
IVGN
83.07 84.30 -1.46
Luminex
LMNZ
16.54 16.33 1.29
MDS
MDZ
22.14 21.96 0.82
Millipore
MIL
74.80 74.50 0.40
PerkinElmer
PKI
27.83 29.50 -5.66
Qiagen
QGEN
23.55 21.20 11.08
Sequenom
SQNM
9.67 10.58 -8.60
Sigma-Aldrich
SIAL
50.95 50.11 1.68
Thermo
TMO
58.13 59.51 -2.32
Third Wave
TWTI
9.43 9.59 -1.67
Waters
WAT
75.22 73.92 1.76
BCW Index Average 42.62 42.98 -0.84
The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.